Novavax stock remains volatile. After hitting a two-year high in June on enthusiasm for its updated Covid vaccine, shares have pulled back.
In the most recent trading session, Novavax (NVAX) closed at $12.91, indicating a +1.77% shift from the previous trading day.
Novavax Inc (NVAX) reports significant revenue from Sanofi partnership and outlines strategic shifts to enhance future growth potential.